Previous close | 6.17 |
Open | 5.92 |
Bid | 6.00 x 0 |
Ask | 6.05 x 0 |
Day's range | 5.92 - 5.92 |
52-week range | 5.92 - 9.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets (*CORRECTION to the release that was posted earlier on January 18, 2024: The TR-4 Return Padisapproved for use by the U.S. Food & Drug Administration (as ...
Approval Represents an Important Breakthrough in One of the Largest Medical Aesthetics Markets LAVAL, QC / ACCESSWIRE / January 18, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and Solta Medical, a global leader in the medical aesthetics ...